Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 145 entries
Sorted by: Best Match Show Resources per page
Pull-off force measurements between rough surfaces by atomic force microscopy.

Journal of colloid and interface science

Beach ER, Tormoen GW, Drelich J, Han R.
PMID: 16290443
J Colloid Interface Sci. 2002 Mar 01;247(1):84-99. doi: 10.1006/jcis.2001.8126.

Direct measurements of the pull-off (adhesion) forces between pharmaceutical particles (beclomethasone dipropionate, a peptide-type material, and lactose) with irregular geometry and rough polymeric surfaces (series of polypropylene coatings, polycarbonate, and acrylonitrile-butadiene-styrene) were carried out using the atomic force microscope....

Cite
Beach ER, Tormoen GW, Drelich J, et al. Pull-off force measurements between rough surfaces by atomic force microscopy. J Colloid Interface Sci. 2002;247(1):84-99doi: 10.1006/jcis.2001.8126.
Beach, E. R., Tormoen, G. W., Drelich, J., & Han, R. (2002). Pull-off force measurements between rough surfaces by atomic force microscopy. Journal of colloid and interface science, 247(1), 84-99. https://doi.org/10.1006/jcis.2001.8126
Beach, E R, et al. "Pull-off force measurements between rough surfaces by atomic force microscopy." Journal of colloid and interface science vol. 247,1 (2002): 84-99. doi: https://doi.org/10.1006/jcis.2001.8126
Beach ER, Tormoen GW, Drelich J, Han R. Pull-off force measurements between rough surfaces by atomic force microscopy. J Colloid Interface Sci. 2002 Mar 01;247(1):84-99. doi: 10.1006/jcis.2001.8126. PMID: 16290443.
Copy Download .nbib Format: NLM
Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma.

Clinical drug investigation

Bracamonte T, Schauer U, Emeryk A, Godwood A, Balsara S.
PMID: 17523742
Clin Drug Investig. 2005;25(1):1-11. doi: 10.2165/00044011-200525010-00001.

BACKGROUND AND OBJECTIVE: Salmeterol and fluticasone propionate are well established in the treatment of childhood asthma, and their combination is effective in children aged 4-11 years. Asthma guidelines recommend that the inhaler device best suited to the individual should...

Cite
Bracamonte T, Schauer U, Emeryk A, et al. Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma. Clin Drug Investig. 2005;25(1):1-11doi: 10.2165/00044011-200525010-00001.
Bracamonte, T., Schauer, U., Emeryk, A., Godwood, A., & Balsara, S. (2005). Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma. Clinical drug investigation, 25(1), 1-11. https://doi.org/10.2165/00044011-200525010-00001
Bracamonte, Teresa, et al. "Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma." Clinical drug investigation vol. 25,1 (2005): 1-11. doi: https://doi.org/10.2165/00044011-200525010-00001
Bracamonte T, Schauer U, Emeryk A, Godwood A, Balsara S. Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma. Clin Drug Investig. 2005;25(1):1-11. doi: 10.2165/00044011-200525010-00001. PMID: 17523742.
Copy Download .nbib Format: NLM
Regulation of CYP3A genes by glucocorticoids in human lung cells.

F1000Research

Roberts JK, Moore CD, Romero EG, Ward RM, Yost GS, Reilly CA.
PMID: 24555085
F1000Res. 2013 Aug 13;2:173. doi: 10.12688/f1000research.2-173.v2. eCollection 2013.

Inhaled glucocorticoids are the first-line treatment for patients with persistent asthma.  However, approximately thirty percent of patients exhibit glucocorticoid insensitivity, which may involve excess metabolic clearance of the glucocorticoids by CYP3A enzymes in the lung.  CYP3A4, 3A5, and 3A7...

Cite
Roberts JK, Moore CD, Romero EG, et al. Regulation of CYP3A genes by glucocorticoids in human lung cells. F1000Res. 2013;2:173doi: 10.12688/f1000research.2-173.v2.
Roberts, J. K., Moore, C. D., Romero, E. G., Ward, R. M., Yost, G. S., & Reilly, C. A. (2013). Regulation of CYP3A genes by glucocorticoids in human lung cells. F1000Research, 2173. https://doi.org/10.12688/f1000research.2-173.v2
Roberts, Jessica K, et al. "Regulation of CYP3A genes by glucocorticoids in human lung cells." F1000Research vol. 2 (2013): 173. doi: https://doi.org/10.12688/f1000research.2-173.v2
Roberts JK, Moore CD, Romero EG, Ward RM, Yost GS, Reilly CA. Regulation of CYP3A genes by glucocorticoids in human lung cells. F1000Res. 2013 Aug 13;2:173. doi: 10.12688/f1000research.2-173.v2. eCollection 2013. PMID: 24555085; PMCID: PMC3869485.
Copy Download .nbib Format: NLM
A study of inhaled beclomethasone dipropionate therapy in asthma.

Canadian family physician Medecin de famille canadien

Epstein SW, Thompson GL.
PMID: 21308039
Can Fam Physician. 1976 Mar;22:62-6.

Fourteen patients with asthma have been followed in a long term clinical trial of the inhaled synthetic corticosteroid, beclomethasone dipropionate. All the patients were corticosteroid-dependent, with significant corticosteroid adverse effects. Twelve of the patients were able to stay on...

Cite
Epstein SW, Thompson GL. A study of inhaled beclomethasone dipropionate therapy in asthma. Can Fam Physician. 1976;22:62-6
Epstein, S. W., & Thompson, G. L. (1976). A study of inhaled beclomethasone dipropionate therapy in asthma. Canadian family physician Medecin de famille canadien, 2262-6.
Epstein, S W, and Thompson, G L. "A study of inhaled beclomethasone dipropionate therapy in asthma." Canadian family physician Medecin de famille canadien vol. 22 (1976): 62-6.
Epstein SW, Thompson GL. A study of inhaled beclomethasone dipropionate therapy in asthma. Can Fam Physician. 1976 Mar;22:62-6. PMID: 21308039; PMCID: PMC2378305.
Copy Download .nbib Format: NLM
Can HLA-DRB4 Help to Identify Asthmatic Patients at Risk of Churg-Strauss Syndrome?.

ISRN rheumatology

Bottero P, Motta F, Bonini M, Vecchio F, Ierna F, Cuppari I, Sinico RA.
PMID: 24734195
ISRN Rheumatol. 2014 Mar 06;2014:843804. doi: 10.1155/2014/843804. eCollection 2014.

HLA-DRB4 gene is associated with Churg-Strauss syndrome (CSS), a systemic eosinophilic vasculitis with a prodromal phase characterized by severe asthma, eosinophilia, nasal polyposis, and sinusitis. Aim of this study was to evaluate if the presence of HLA-DRB4 in asthmatic...

Cite
Bottero P, Motta F, Bonini M, et al. Can HLA-DRB4 Help to Identify Asthmatic Patients at Risk of Churg-Strauss Syndrome?. ISRN Rheumatol. 2014;2014:843804doi: 10.1155/2014/843804.
Bottero, P., Motta, F., Bonini, M., Vecchio, F., Ierna, F., Cuppari, I., & Sinico, R. A. (2014). Can HLA-DRB4 Help to Identify Asthmatic Patients at Risk of Churg-Strauss Syndrome?. ISRN rheumatology, 2014843804. https://doi.org/10.1155/2014/843804
Bottero, P, et al. "Can HLA-DRB4 Help to Identify Asthmatic Patients at Risk of Churg-Strauss Syndrome?." ISRN rheumatology vol. 2014 (2014): 843804. doi: https://doi.org/10.1155/2014/843804
Bottero P, Motta F, Bonini M, Vecchio F, Ierna F, Cuppari I, Sinico RA. Can HLA-DRB4 Help to Identify Asthmatic Patients at Risk of Churg-Strauss Syndrome?. ISRN Rheumatol. 2014 Mar 06;2014:843804. doi: 10.1155/2014/843804. eCollection 2014. PMID: 24734195; PMCID: PMC3963189.
Copy Download .nbib Format: NLM
Evaluation of Efficacy of Different Topical Corticosteroids.

Indian journal of dermatology, venereology and leprology

Prasad G, Prasad BN.
PMID: 28150628
Indian J Dermatol Venereol Leprol. 1986 Jan-Feb;52(1):30-32.

Four different, proprietary preparations of topical cortico-steroids in cream base were evaluated for their relative efficacy on forty adult human volunteers using a modification of the method described by Reddy and Singh. Fluocinolone acetonide 0.025% (Flucort) was rated to...

Cite
Prasad G, Prasad BN. Evaluation of Efficacy of Different Topical Corticosteroids. Indian J Dermatol Venereol Leprol. 1986;52(1):30-32
Prasad, G., & Prasad, B. N. (1986). Evaluation of Efficacy of Different Topical Corticosteroids. Indian journal of dermatology, venereology and leprology, 52(1), 30-32.
Prasad, G, and Prasad, B N. "Evaluation of Efficacy of Different Topical Corticosteroids." Indian journal of dermatology, venereology and leprology vol. 52,1 (1986): 30-32.
Prasad G, Prasad BN. Evaluation of Efficacy of Different Topical Corticosteroids. Indian J Dermatol Venereol Leprol. 1986 Jan-Feb;52(1):30-32. PMID: 28150628.
Copy Download .nbib Format: NLM
Asthma as a hidden disease in rural China: opportunities and challenges of standard case management.

Public health action

Kan XH, Chiang CY, Enarson DA, Rao HL, Chen Q, Aït-Khaled N, Chen GW.
PMID: 26392959
Public Health Action. 2012 Sep 21;2(3):87-91. doi: 10.5588/pha.12.0025.

OBJECTIVE: To assess the implementation of standard case management of asthma in Huaiyuan County, Anhui Province, China, in 2008.DESIGN: The study project began with the local adaptation of international asthma guidelines, followed by a situation analysis, pre-intervention study, training...

Cite
Kan XH, Chiang CY, Enarson DA, et al. Asthma as a hidden disease in rural China: opportunities and challenges of standard case management. Public Health Action. 2012;2(3):87-91doi: 10.5588/pha.12.0025.
Kan, X. H., Chiang, C. Y., Enarson, D. A., Rao, H. L., Chen, Q., Aït-Khaled, N., & Chen, G. W. (2012). Asthma as a hidden disease in rural China: opportunities and challenges of standard case management. Public health action, 2(3), 87-91. https://doi.org/10.5588/pha.12.0025
Kan, X H, et al. "Asthma as a hidden disease in rural China: opportunities and challenges of standard case management." Public health action vol. 2,3 (2012): 87-91. doi: https://doi.org/10.5588/pha.12.0025
Kan XH, Chiang CY, Enarson DA, Rao HL, Chen Q, Aït-Khaled N, Chen GW. Asthma as a hidden disease in rural China: opportunities and challenges of standard case management. Public Health Action. 2012 Sep 21;2(3):87-91. doi: 10.5588/pha.12.0025. PMID: 26392959; PMCID: PMC4463046.
Copy Download .nbib Format: NLM
Efficacy of pharmacological agents for ulcerative proctitis: a systematic literature review.

Journal of Crohn's & colitis

Caron B, Sandborn WJ, Panaccione R, Schreiber S, Hart A, Solitano V, Danese S, Peyrin-Biroulet L.
PMID: 34850857
J Crohns Colitis. 2021 Nov 30; doi: 10.1093/ecco-jcc/jjab218. Epub 2021 Nov 30.

BACKGROUND: Ulcerative proctitis is a common and often highly symptomatic form of inflammatory bowel disease. We performed a systematic review to assess the efficacy of different therapies in the management of patients with ulcerative proctitis.METHODS: We identified randomized controlled...

Cite
Caron B, Sandborn WJ, Panaccione R, et al. Efficacy of pharmacological agents for ulcerative proctitis: a systematic literature review. J Crohns Colitis. 2021;doi: 10.1093/ecco-jcc/jjab218.
Caron, B., Sandborn, W. J., Panaccione, R., Schreiber, S., Hart, A., Solitano, V., Danese, S., & Peyrin-Biroulet, L. (2021). Efficacy of pharmacological agents for ulcerative proctitis: a systematic literature review. Journal of Crohn's & colitis, . https://doi.org/10.1093/ecco-jcc/jjab218
Caron, Bénédicte, et al. "Efficacy of pharmacological agents for ulcerative proctitis: a systematic literature review." Journal of Crohn's & colitis vol. (2021). doi: https://doi.org/10.1093/ecco-jcc/jjab218
Caron B, Sandborn WJ, Panaccione R, Schreiber S, Hart A, Solitano V, Danese S, Peyrin-Biroulet L. Efficacy of pharmacological agents for ulcerative proctitis: a systematic literature review. J Crohns Colitis. 2021 Nov 30; doi: 10.1093/ecco-jcc/jjab218. Epub 2021 Nov 30. PMID: 34850857.
Copy Download .nbib Format: NLM
Association between inhaled corticosteroid use and SARS-CoV-2 infection: A nationwide population-based study in South Korea.

Tuberculosis and respiratory diseases

Lee SC, Son KJ, Han CH, Jung JY, Park SC.
PMID: 34844402
Tuberc Respir Dis (Seoul). 2021 Nov 30; doi: 10.4046/trd.2021.0102. Epub 2021 Nov 30.

BACKGROUND: Inhaled corticosteroid (ICS) use may increase the risk of respiratory infection, but its influence on the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is not known. This study aimed to investigate the association between ICS...

Cite
Lee SC, Son KJ, Han CH, et al. Association between inhaled corticosteroid use and SARS-CoV-2 infection: A nationwide population-based study in South Korea. Tuberc Respir Dis (Seoul). 2021;doi: 10.4046/trd.2021.0102.
Lee, S. C., Son, K. J., Han, C. H., Jung, J. Y., & Park, S. C. (2021). Association between inhaled corticosteroid use and SARS-CoV-2 infection: A nationwide population-based study in South Korea. Tuberculosis and respiratory diseases, . https://doi.org/10.4046/trd.2021.0102
Lee, Sang Chul, et al. "Association between inhaled corticosteroid use and SARS-CoV-2 infection: A nationwide population-based study in South Korea." Tuberculosis and respiratory diseases vol. (2021). doi: https://doi.org/10.4046/trd.2021.0102
Lee SC, Son KJ, Han CH, Jung JY, Park SC. Association between inhaled corticosteroid use and SARS-CoV-2 infection: A nationwide population-based study in South Korea. Tuberc Respir Dis (Seoul). 2021 Nov 30; doi: 10.4046/trd.2021.0102. Epub 2021 Nov 30. PMID: 34844402.
Copy Download .nbib Format: NLM
Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma.

The journal of allergy and clinical immunology. In practice

Alahmadi FH, Keevil B, Elsey L, George K, Niven R, Fowler SJ.
PMID: 34153519
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4279-4287.e6. doi: 10.1016/j.jaip.2021.05.041. Epub 2021 Jun 18.

BACKGROUND: Daily inhaled corticosteroids (ICSs) are fundamental to asthma management, but adherence is low.OBJECTIVES: To investigate (1) whether LC-MS/MS could be used to detect ICSs in serum and (2) whether serum levels related to markers of disease severity.METHODS: We...

Cite
Alahmadi FH, Keevil B, Elsey L, et al. Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma. J Allergy Clin Immunol Pract. 2021;9(12):4279-4287.e6doi: 10.1016/j.jaip.2021.05.041.
Alahmadi, F. H., Keevil, B., Elsey, L., George, K., Niven, R., & Fowler, S. J. (2021). Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma. The journal of allergy and clinical immunology. In practice, 9(12), 4279-4287.e6. https://doi.org/10.1016/j.jaip.2021.05.041
Alahmadi, Fahad H, et al. "Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma." The journal of allergy and clinical immunology. In practice vol. 9,12 (2021): 4279-4287.e6. doi: https://doi.org/10.1016/j.jaip.2021.05.041
Alahmadi FH, Keevil B, Elsey L, George K, Niven R, Fowler SJ. Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4279-4287.e6. doi: 10.1016/j.jaip.2021.05.041. Epub 2021 Jun 18. PMID: 34153519.
Copy Download .nbib Format: NLM
Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β.

Chest

Wang MT, Lai JH, Huang YL, Liou JT, Cheng SH, Lin CW, Pan HY, Hsu YJ, Tsai CL.
PMID: 34023320
Chest. 2021 Oct;160(4):1255-1270. doi: 10.1016/j.chest.2021.05.025. Epub 2021 May 21.

BACKGROUND: Despite multiple available fixed-dose combinations (FDCs) of inhaled long-acting βRESEARCH QUESTION: Can comparative effectiveness and safety of LABA plus LAMA (LABA/LAMA) and LABA plus ICS (LABA/ICS) FDCs vary by different individual components of the dual combinations in COPD?STUDY...

Cite
Wang MT, Lai JH, Huang YL, et al. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β. Chest. 2021;160(4):1255-1270doi: 10.1016/j.chest.2021.05.025.
Wang, M. T., Lai, J. H., Huang, Y. L., Liou, J. T., Cheng, S. H., Lin, C. W., Pan, H. Y., Hsu, Y. J., & Tsai, C. L. (2021). Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β. Chest, 160(4), 1255-1270. https://doi.org/10.1016/j.chest.2021.05.025
Wang, Meng-Ting, et al. "Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β." Chest vol. 160,4 (2021): 1255-1270. doi: https://doi.org/10.1016/j.chest.2021.05.025
Wang MT, Lai JH, Huang YL, Liou JT, Cheng SH, Lin CW, Pan HY, Hsu YJ, Tsai CL. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β. Chest. 2021 Oct;160(4):1255-1270. doi: 10.1016/j.chest.2021.05.025. Epub 2021 May 21. PMID: 34023320.
Copy Download .nbib Format: NLM
Loading of Beclomethasone in Liposomes and Hyalurosomes Improved with Mucin as Effective Approach to Counteract the Oxidative Stress Generated by Cigarette Smoke Extract.

Nanomaterials (Basel, Switzerland)

Manca ML, Ferraro M, Pace E, Di Vincenzo S, Valenti D, Fernàndez-Busquets X, Peptu CA, Manconi M.
PMID: 33810420
Nanomaterials (Basel). 2021 Mar 26;11(4). doi: 10.3390/nano11040850.

In this work beclomethasone dipropionate was loaded into liposomes and hyalurosomes modified with mucin to improve the ability of the payload to counteract the oxidative stress and involved damages caused by cigarette smoke in the airway. The vesicles were...

Cite
Manca ML, Ferraro M, Pace E, et al. Loading of Beclomethasone in Liposomes and Hyalurosomes Improved with Mucin as Effective Approach to Counteract the Oxidative Stress Generated by Cigarette Smoke Extract. Nanomaterials (Basel). 2021;11(4)doi: 10.3390/nano11040850.
Manca, M. L., Ferraro, M., Pace, E., Di Vincenzo, S., Valenti, D., Fernàndez-Busquets, X., Peptu, C. A., & Manconi, M. (2021). Loading of Beclomethasone in Liposomes and Hyalurosomes Improved with Mucin as Effective Approach to Counteract the Oxidative Stress Generated by Cigarette Smoke Extract. Nanomaterials (Basel, Switzerland), 11(4), . https://doi.org/10.3390/nano11040850
Manca, Maria Letizia, et al. "Loading of Beclomethasone in Liposomes and Hyalurosomes Improved with Mucin as Effective Approach to Counteract the Oxidative Stress Generated by Cigarette Smoke Extract." Nanomaterials (Basel, Switzerland) vol. 11,4 (2021). doi: https://doi.org/10.3390/nano11040850
Manca ML, Ferraro M, Pace E, Di Vincenzo S, Valenti D, Fernàndez-Busquets X, Peptu CA, Manconi M. Loading of Beclomethasone in Liposomes and Hyalurosomes Improved with Mucin as Effective Approach to Counteract the Oxidative Stress Generated by Cigarette Smoke Extract. Nanomaterials (Basel). 2021 Mar 26;11(4). doi: 10.3390/nano11040850. PMID: 33810420; PMCID: PMC8065961.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 145 entries